Home
/ Healthcare & Medicine / Bioinformatics / From Lab to Clinic: Translational Research for Rare Diseases / Role of Patient Advocacy Organizations in drug repurposing and a successful repurposing case
Role of Patient Advocacy Organizations in drug repurposing and a successful repurposing case
The synergy between patients, researchers and industry is fundamental to boost drug repurposing. Watch Rick Thompson explain why and how.
The role of people living with a rare disease is fundamental in promoting preclinical and clinical research for rare diseases and this is also true for drug repurposing. Rick Thompson will now explain why and how, also by illustrating the successful case of Nitisione, a drug used for the treatment of Alkaptonuria.
This article is from the online course:
From Lab to Clinic: Translational Research for Rare Diseases
Created by
This article is from the free online
From Lab to Clinic: Translational Research for Rare Diseases
